Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
N
Nxera Pharma Co Ltd
TSE:4565
Nxera Pharma Co Ltd
TSE:4565
Price:
1 264
JPY
1.2%
Market Closed
Market Cap:
¥117.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
Nxera Pharma Co Ltd
TSE:4565
|
JP |
|
E
|
Enbridge Inc
DUS:EN3
|
CA |
|
Angus Energy PLC
LSE:ANGS
|
UK |
|
T
|
Target Corp
F:DYH
|
US |
|
T
|
TDT Investment and Development JSC
VN:TDT
|
VN |
|
N
|
Nova klubburinn hf
ICEX:NOVA
|
IS |
|
Midsummer AB
STO:MIDS
|
SE |
|
Solaris Oilfield Infrastructure Inc
NYSE:SEI
|
US |
|
Tertiary Minerals PLC
LSE:TYM
|
UK |
|
W
|
Wheaton Precious Metals Corp
NYSE:WPM
|
CA |
|
L
|
Live Energy Minerals Corp
CNSX:LIVE
|
CA |
|
D
|
DRDGOLD Ltd
XMUN:DUB1
|
ZA |
|
X
|
Xenia Hotels & Resorts Inc
F:0XHR
|
US |
|
M
|
Maze Therapeutics Inc
NASDAQ:MAZE
|
US |
|
Tesco PLC
LSE:TSCO
|
UK |
|
P
|
Peking University Resources (Holdings) Company Ltd
HKEX:618
|
HK |
|
PTC India Ltd
NSE:PTC
|
IN |
|
G
|
Glencore PLC
SWB:8GC
|
CH |
|
Invex Therapeutics Ltd
ASX:IXC
|
AU |
|
Samsung Electro-Mechanics Co Ltd
KRX:009150
|
KR |
|
P
|
PNC Financial Services Group Inc
SWB:PNP
|
US |
|
GSR IV Acquisition Corp
NASDAQ:GSRF
|
US |
|
C
|
Com2uS Holdings Corp
KOSDAQ:063080
|
KR |
|
Cosmos Pharmaceutical Corp
TSE:3349
|
JP |
Wall St Price Targets
Price Forecast
Based on 10 analysts
Based on 10 analysts
+49% Upside
from
¥1 264
today
Nxera Pharma Co Ltd (4565)’s 12-month stock price forecast through October 2027 has a consensus target of ¥1 887, implying 49% upside. The forecast is based on price targets from 10 Wall Street analysts.
Nxera Pharma Co Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Nxera Pharma Co Ltd's stock price target?
Price Target
1 887
JPY
1 887
JPY
According to Wall Street analysts, the average 1-year price target for Nxera Pharma Co Ltd is 1 887 JPY with a low forecast of 1 010 JPY and a high forecast of 4 725 JPY.
What is the Revenue forecast for Nxera Pharma Co Ltd?
Projected CAGR
22%
22%
Over the last 6 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 3 years is 22%.
What is the Gross Profit forecast for Nxera Pharma Co Ltd?
Projected CAGR
23%
23%
Over the last 6 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 3 years is 23%.